Medicare Monitor. How a whistle-blower spurred pricing case involving drug makers. High U.S. reimbursement caught eye of newcomer to home-care business. Toilet seat as a talking point.

Number 20431
Subject Medical Reporting
Source Wall Street Journal (New York)
State NY
Year 2000
Publication Date May 12, 2000
Summary According to the article, "Today, federal and state investigators are threatening civil litigation against pharmaceutical makers that authorities believe have induced Medicare and Medicaid to overpay for prescription drugs by $1 billion or more a year." This article talks about that controversy.
Category General
Pages 2
Keywords prescription drugs;pharmaceutical makers;Medicare;Medicaid;money;medicine;prescriptions;pills
Related Links
Related Video
Ordering info Want to place an order? Email us or call us at 573-882-3364 (Stories are only available to members of IRE. For membership information, please refer to our membership page)